Armata Pharmaceuticals, Inc. Common Stock
Symbol: ARMP (NYSE)
2.98
▲ (1.06%) 0.031
Company Description:
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
Key Stats
- Today's Open: $2.83
- Today's High: $2.98
- Today's Low: $2.81
- Today's Volume: 5.33K
- Yesterday Close: $2.9487
- Yesterday High: $2.982
- Yesterday Low: $2.79
- Yesterday Volume: 4.73K
- Last Min Volume: 1
- Last Min High: $2.98
- Last Min Low: $2.98
- Last Min VWAP: $2.98
Company Profile
- Name: Armata Pharmaceuticals, Inc. Common Stock
- Website: https://www.armatapharma.com
- Listed Date: 1994-05-27
- Location: LOS ANGELES, CA
- Market Status: Active
- CIK Number: 0000921114
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $102.17M
- Round Lot: 100
- Outstanding Shares: 36.23M
- Asset Type: CS
RECENT FILINGS FOR ARMP
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-22 | EFFECT | View |
| 2025-08-13 | S-8 | View |
| 2025-08-13 | S-3 | View |
| 2025-08-12 | SCHEDULE 13D/A | View |
| 2025-08-12 | 10-Q | View |
| 2025-08-12 | 8-K | View |
| 2025-07-14 | 4 | View |
| 2025-06-13 | 8-K | View |
| 2025-05-19 | 8-K | View |
| 2025-05-14 | 10-Q | View |
| 2025-05-14 | 8-K | View |
| 2025-05-01 | 8-K | View |
| 2025-04-28 | ARS | View |
| 2025-04-28 | DEF 14A | View |
| 2025-04-25 | 4 | View |
| 2025-04-25 | 4 | View |
| 2025-04-25 | 3/A | View |
| 2025-04-02 | 8-K | View |
| 2025-03-21 | 10-K | View |
| 2025-03-21 | 8-K | View |
Latest News on ARMP